First Choice Neurology

Sardion Jijelava, MD

Sardion Jijelava, MD

Sardion Jijelava, MDSardion Jijelava, MD, is a Neurologist in Aventura, Florida. He is board-certified in Neurology by the American Osteopathic Board of Neurology and Psychiatry (AOBNP).

Dr. Jijelava provides comprehensive, compassionate care for patients with disorders of the brain, spine, nerves, and muscles. With his clinical experience, Dr. Jijelava is known for taking the time to listen, explaining diagnoses clearly, and building individualized treatment plans with each patient. He takes care of every single patient as an individual. Compassion and shared decision-making are at the heart of his practice. He works closely with patients and their families to understand their goals and builds a diagnostic and treatment plan together.

Dr. Jijelava evaluates and treats a broad range of neurological conditions, with particular interest in headache and migraine, epilepsy and seizure disorders, neuromuscular disorders, neuropathy, movement disorders such as Parkinson's disease, dementia and Alzheimer's disease, and stroke prevention and recovery. He also performs EEGs, EMGs, and nerve conduction studies, Botox for chronic migraine and spasticity, and other procedures.

When not seeing patients, Dr. Jijelava enjoys spending time with his family, carpentry, and connecting with people through community events. He is a lifelong car enthusiast. Whether he is exploring classic and modern models or heading out for a good drive, cars are his favorite way to recharge.

Specialties
ALS, Alzheimer’s Disease, Back Pain, Balance, Botox Injections, Botulinum Toxins, Carpal Tunnel Syndrome, Concussion, COVID-19 Long Haulers, Dementia, Dizziness, Electromyography, Epilepsy, Facial Pain, Familial Amyloid Polyneuropathy, Gait Disorders, Headaches/Migraines, Memory, Movement Disorders, Myasthenia Gravis, Neck and Back Pain, Neurology, Neuromuscular Disorders, Neuropathy, Neurophysiology, Numbness, Parkinson’s Disease, Seizures, Spasticity, Spine Disorders, Stroke, Tingling, Traumatic Brain Injury, Tremors, Vertigo

Board Certifications
American Osteopathic Board of Neurology and Psychiatry (AOBNP)

Medical Interests
Dr. Jijelava's clinical interests include stroke, migraine and other headache disorders, epilepsy, peripheral neuropathy, neuromuscular disorders, movement disorders such as Parkinson's disease, and memory disorders, including dementia and Alzheimer's disease.

Education
Tbilisi State Medical University

Residency 
Nuvance Health Neurology Residency - Poughkeepsie, New York

Fellowships
Clinical Neurophysiology fellowship - University of Southern California, Los Angeles, CA

Memberships
American Academy of Neurology

Accepts New Patients
Yes

Insurance 
List of insurance plans accepted

Languages
English, Russian, Georgian, Megrelian

Location
21000 NE 28th Avenue, Suite 205
Aventura, FL 33180
Phone: (305) 933-5993
Fax: (305) 933-9415

Office Hours
Monday - Friday
8:00 AM - 5:00 PM

 

Research & Clinical Trials
1. Middle Meningeal Artery Embolization in the Treatment of Acute Subdural Hematoma: A Case Series Featuring Access through a Carotid Stent. https://kjnt.org/pdf/10.13004/kjnt.2024.20.e16.
2. Healey ALS Platform Trial. Perpetual Multi-Center, Multi-Regimen Clinical Trial Evaluating the Safety and Efficacy of Investigational Products for the Treatment of ALS (Regimen F: ABBV-CLS-7262). Merit E. Cudkowicz, MD (Center Study PI), Sean Healey & AMG Center for ALS at Mass General Hospital.
3. Healey ALS Platform Trial. Perpetual Multi-Center, Multi-Regimen Clinical Trial Evaluating the Safety and Efficacy of Investigational Products for the Treatment of ALS (Regimen G: DML343). Merit E. Cudkowicz, MD (Center Study PI), Sean Healey & AMG Center for ALS at Mass General Hospital.
4. A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis. Abcuro Pharmaceuticals.
5. Efficacy and Safety of Pozelimab and Cemdisiran Combined Therapy in Patients with Symptomatic Generalized Myasthenia Gravis. Regeneron Pharmaceuticals.
6. A phase 2, randomized, double-blind, placebo-controlled parallel group study of VHB937 in Amyotrophic Lateral Sclerosis (ALS) over 40 weeks followed by an Open-label Extension (ASTRALS), Novartis Pharmaceuticals.
7. A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study with an Open-label Extension Period to Evaluate the Efficacy and Safety of Telitacicept in Patients with Generalized Myasthenia Gravis, RemeGen Pharmaceuticals.

Publication
Middle Meningeal Artery Embolization in the Treatment of Acute Subdural Hematoma: A Case Series Featuring Access through a Carotid Stent.

 

Sardion Jijelava, MD, is a board-certified neurologist in Aventura, Florida. Call the office at (305) 933-5993 to schedule an appointment.

Translate »